More than half of all women will have a lump or nodule in their breast, but most lumps and nodules are not cancer
Prior to the granting of marketing authorisation by the MHRA, Biyze® had been approved by the European Commission for a number of indications and is currently the only drug approved for the treatment of MZL in Great Britain.
